Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Non-Current Liabilities (2016 - 2025)

Marimed (MRMD) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $151.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 4.45% to $151.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $151.2 million, a 4.45% increase, with the full-year FY2024 number at $128.0 million, up 19.52% from a year prior.
  • Total Non-Current Liabilities was $151.2 million for Q3 2025 at Marimed, up from $147.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $151.2 million in Q3 2025 to a low of $37.5 million in Q1 2021.
  • A 5-year average of $92.1 million and a median of $91.9 million in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: plummeted 36.32% in 2021, then skyrocketed 114.18% in 2023.
  • Marimed's Total Non-Current Liabilities stood at $49.1 million in 2021, then grew by 16.27% to $57.1 million in 2022, then surged by 87.69% to $107.1 million in 2023, then increased by 19.52% to $128.0 million in 2024, then increased by 18.1% to $151.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Total Non-Current Liabilities are $151.2 million (Q3 2025), $147.3 million (Q2 2025), and $150.1 million (Q1 2025).